BACKGROUND Interstitial lung disease (ILD) is the leading cause of morbidity and mortality
in patients with systemic sclerosis (SSc); however, prognostication of SSc-associated ILD (…

Rationale: As the life expectancy for individuals with cystic fibrosis (CF) continues to improve,
an emphasis on optimizing health-related quality of life (HRQoL) has become increasingly …

Background Biomarkers reflective of disease activity in cystic fibrosis (CF) have the potential
to improve patient care, particularly during CF pulmonary exacerbations (CFPEs). Although …

Infection with Burkholderia cepacia complex in patients with cystic fibrosis (CF) results in
highly variable clinical outcomes. The purpose of this study was to determine if there are …

Background . The long-term outcome and spectrum of disease of nontuberculous mycobacterial
immune reconstitution syndrome have not been described. Methods . We report the …

Background Pulmonary rehabilitation improves outcomes in patients with interstitial lung
disease (ILD), however it is unclear whether these effects are long lasting and which patients …

Background We did a randomised, double-blind, controlled clinical trial to prospectively assess
whether use of combination antibiotic susceptibility testing improved clinical outcomes in …

Assessment of the breathing pattern at maximal exercise in patients is limited because the
range of ventilatory responses (minute ventilation; tidal volume; respiratory rate) at maximal …

Rationale: We have been collecting Burkholderia species bacteria from patients with cystic
fibrosis (CF) for the last 30 years. During this time, our understanding of their multispecies …

Atelectasis following coronary artery bypass surgery (CAB) occurs in the majority of patients.
To determine the importance of operative variables in the development of postoperative …